Items where authors include "Emery, P"

Export as [feed] Atom [feed] RSS
Number of items: 398.

Article

Tuttle, J, Drescher, E, Simón-Campos, JA et al. (7 more authors) (2023) A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. New England Journal of Medicine, 388 (20). pp. 1853-1862. ISSN 0028-4793

Carter, LM orcid.org/0000-0002-8724-5937, Alase, A, Wigston, Z et al. (10 more authors) (2023) Gene expression and autoantibody analysis reveals distinct ancestry-specific profiles associated with response to rituximab in refractory systemic lupus erythematosus. Arthritis & Rheumatology, 75 (5). pp. 697-710. ISSN 2326-5191

Siddle, HJ orcid.org/0000-0002-6015-332X, Bradley, SH orcid.org/0000-0002-2038-2056, Anderson, AM orcid.org/0000-0002-4048-6880 et al. (3 more authors) (2023) Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. British Journal of General Practice, 73 (729). pp. 152-154. ISSN 0960-1643

van Ouwerkerk, L, Boers, M, Emery, P orcid.org/0000-0002-7429-8482 et al. (8 more authors) (2023) Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82 (4). pp. 468-475. ISSN 0003-4967

Volkmann, ER, Sparks, JA, Hoffmann-Vold, A-M et al. (3 more authors) (2023) Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences. The Lancet Rheumatology, 5 (3). e116-e118. ISSN 2665-9913

Md Yusof, MY orcid.org/0000-0003-3131-9121, Arnold, J, Saleem, B et al. (5 more authors) (2023) Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study. The Lancet Rheumatology, 5 (2). e88-e98. ISSN 2665-9913

Curtis, JR, Stolshek, B, Emery, P orcid.org/0000-0002-7429-8482 et al. (6 more authors) (2023) Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology, 29 (1). pp. 16-22. ISSN 1076-1608

Biglands, JD orcid.org/0000-0002-1161-5022, Erhayiem, B, Fent, G et al. (6 more authors) (2022) No differences in myocardial perfusion between treatment-naive, early rheumatoid arthritis patients and healthy controls. Arthritis and Rheumatology, 75 (1). pp. 141-142. ISSN 2326-5191

Taylor, CA, Watson, RA, Tong, O et al. (22 more authors) (2022) IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature Medicine, 28 (12). pp. 2592-2600. ISSN 1078-8956

Ponchel, F orcid.org/0000-0002-3969-7701, Duquenne, L, Xie, X et al. (5 more authors) (2022) Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD Open, 8 (2). e002512. ISSN 2056-5933

Robinson, JI orcid.org/0000-0001-5425-7520, Md Yusof, MY orcid.org/0000-0003-3131-9121, Davies, V et al. (20 more authors) (2022) Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. eBioMedicine, 86. 104343. ISSN 2352-3964

Pepple, S, Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755 et al. (5 more authors) (2022) Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome. ACR Open Rheumatology, 4 (8). pp. 689-699. ISSN 2578-5745

Aletaha, D, Kerschbaumer, A, Kastrati, K et al. (41 more authors) (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Bertham, DP, Tan, AL orcid.org/0000-0002-9158-7243, Booth, A et al. (4 more authors) (2022) Repeatability of quantitative MRI in patients with rheumatoid arthritis. Radiography, 28 (3). pp. 831-837. ISSN 1078-8174

Schreiber, S, Puig, L, Gonçalves, J et al. (3 more authors) (2022) Critical Appraisal and Future Outlook on Anti-Inflammatory Biosimilar Use in Chronic Immune-Mediated Inflammatory Diseases. Seminars in Arthritis and Rheumatism, 55. 152023. ISSN 0049-0172

Di Matteo, A, Duquenne, L, Cipolletta, E et al. (6 more authors) (2022) Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum. Rheumatology, 61 (8). pp. 3192-3200. ISSN 1462-0324

Gul, HL, Di Matteo, A, Mankia, K et al. (3 more authors) (2022) Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission? Clinical and Experimental Rheumatology. CER15516. ISSN 1593-098X

Myasoedova, E, Athreya, AP, Crowson, CS et al. (15 more authors) (2022) Towards Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: a Pharmacogenomics-driven Machine Learning Approach. Arthritis Care and Research, 74 (6). pp. 879-888. ISSN 2151-464X

Coates, LC, O'Dwyer, J orcid.org/0000-0002-7212-6089, Meads, D et al. (3 more authors) (2022) Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era. The Lancet Rheumatology, 4 (6). E390-E391. ISSN 2665-9913

Saleem, B, Ross, RL, Bissell, L-A et al. (20 more authors) (2022) Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses. RMD Open, 8 (1). e002050. ISSN 2056-5933

Saleem, B, Ross, RL, Duquenne, L et al. (2 more authors) (2022) COVID-19 vaccine-induced T-cell responses in patients with rheumatoid arthritis: preferential induction by ChAdOx1. The Lancet Rheumatology, 4 (3). e171-e172. ISSN 2665-9913

Ahmad, HA, Baker, JF, Conaghan, P orcid.org/0000-0002-3478-5665 et al. (5 more authors) (2022) Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept. Arthritis Research and Therapy, 24. 47. ISSN 1478-6354

Siddle, HJ orcid.org/0000-0002-6015-332X, Chapman, LS, Mankia, K et al. (9 more authors) (2022) Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies. Annals of the Rheumatic Diseases, 81 (2). pp. 159-168. ISSN 0003-4967

Garcia-Montoya, L, Nam, JL, Duquenne, L et al. (5 more authors) (2022) Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study. Arthritis Research and Therapy, 24. 26. ISSN 1478-6354

Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755, Dass, S et al. (5 more authors) (2022) A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis. Frontiers in Immunology, 12. 803175. ISSN 1664-3224

Rabin, T, De Marco, G, Dubash, SR et al. (5 more authors) (2021) Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis. Clinical and Experimental Rheumatology.

Garcia-Montoya, L and Emery, P orcid.org/0000-0002-7429-8482 (2021) Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials. Expert Opinion on Investigational Drugs, 30 (11). pp. 1109-1124. ISSN 1354-3784

Dubash, S, Alabas, OA, Michelena, X et al. (7 more authors) (2021) Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Tinazzi, I, Mulipa, P, Colato, C et al. (6 more authors) (2021) SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker. Journal of Clinical Medicine, 10 (24). 5820. ISSN 2077-0383

Dubash, SR, Alabas, OA, Michelena, X et al. (8 more authors) (2021) Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritis. Rheumatology Advances in Practice, 5 (3). rkab086. ISSN 2514-1775

Kelly, C, Emery, P orcid.org/0000-0002-7429-8482 and Dieudé, P (2021) Current issues in rheumatoid arthritis associated interstitial lung disease. The Lancet Rheumatology, 3 (11). E798-E807. ISSN 2665-9913

Mahmoud, K, Zayat, AS, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (12 more authors) (2021) Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study. Rheumatology, 60 (11). pp. 5194-5204. ISSN 1462-0324

Shukla, R, Emery, P orcid.org/0000-0002-7429-8482 and Buch, MH orcid.org/0000-0002-8962-5642 (2021) Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the ‘VEDERA’ trial. Rheumatology. ISSN 1462-0324

Mankia, K, Siddle, HJ orcid.org/0000-0002-6015-332X, Kerschbaumer, A et al. (17 more authors) (2021) EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Annals of the Rheumatic Diseases, 80 (10). pp. 1286-1298. ISSN 0003-4967

Mankia, K, Siddle, H, Di Matteo, A et al. (5 more authors) (2021) A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. RMD Open, 7 (3). e001768. ISSN 2056-5933

Wouters, F, Maurits, MP, Van Boheemen, L et al. (9 more authors) (2021) Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482, Breedveld, F, Campos-Alberto, E et al. (2 more authors) (2021) Clinical, Radiologic, and Functional Outcomes Following Methotrexate Withdrawal in Etanercept-Treated Patients with Active Early Rheumatoid Arthritis: A Subanalysis of COMET Year 2 by Week 52 DAS28 Status. Open Rheumatology Journal, 15. pp. 31-38. ISSN 1874-3129

Mankia, K and Emery, P orcid.org/0000-0002-7429-8482 (2021) Should we aim for personalized prevention in individuals at risk of rheumatoid arthritis? International Journal of Rheumatic Diseases, 24 (5). pp. 621-622. ISSN 1756-1841

Curtis, JR, Emery, P orcid.org/0000-0002-7429-8482, Karis, E et al. (5 more authors) (2021) Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission on Combination Therapy: A Randomized, Double‐Blind Trial. Arthritis and Rheumatology, 73 (5). pp. 759-768. ISSN 2326-5191

Ponchel, F orcid.org/0000-0002-3969-7701, Churchman, S, El-Jawhari, JJ et al. (8 more authors) (2021) Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium. Clinical and Experimental Rheumatology, 39 (2). ISSN 0392-856X

Xu, C, Rafique, A, Potocky, T et al. (12 more authors) (2021) Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters. The Journal of Clinical Pharmacology, 61 (5). pp. 714-724. ISSN 0091-2700

Bagnato, G, Pigatto, E, Bitto, A et al. (15 more authors) (2021) The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis. Frontiers in Medicine, 8 (1). 651748. ISSN 2296-858X

Arnold, J, Winthrop, K and Emery, P orcid.org/0000-0002-7429-8482 (2021) COVID-19 vaccination and antirheumatic therapy. Rheumatology. keab223. ISSN 1462-0324

Kim, HU, Alten, R, Cummings, F et al. (14 more authors) (2021) Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs, 13 (1). 1868078. ISSN 1942-0862

Ponchel, F orcid.org/0000-0002-3969-7701, van Delft, MA, Xie, X orcid.org/0000-0002-1474-9931 et al. (4 more authors) (2021) Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis? Clinical and Experimental Rheumatology, 39 (1). 0146-0150. ISSN 0392-856X

Corradini, D, Di Matteo, A, Emery, P orcid.org/0000-0002-7429-8482 et al. (1 more author) (2021) How should we treat palindromic rheumatism? A systematic literature review. Arthritis and Rheumatology, 51 (1). pp. 266-277. ISSN 2326-5191

Farrow, M, Biglands, J orcid.org/0000-0002-1161-5022, Tanner, SF et al. (6 more authors) (2021) The effect of ageing on skeletal muscle as assessed by quantitative MR imaging: an association with frailty and muscle strength. Aging Clinical and Experimental Research, 33 (2). pp. 291-301. ISSN 1594-0667

Psarras, A, Antanaviciute, A, Alase, A et al. (5 more authors) (2021) TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation. The Journal of Immunology. ji1901358. ISSN 0022-1767

Melville, AR, Yusof, Y, Fitton, J orcid.org/0000-0002-7795-8191 et al. (6 more authors) (2021) Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis. Rheumatology. ISSN 1462-0324

Emery, P orcid.org/0000-0002-7429-8482, Durez, P, Hueber, AJ et al. (4 more authors) (2021) Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis – a comprehensive review. Arthritis Research and Therapy, 23 (3). ISSN 1478-6354

Nash, P, Kerschbaumer, A, Dörner, T et al. (26 more authors) (2021) Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the Rheumatic Diseases, 80 (1). pp. 71-87. ISSN 0003-4967

Farrow, M, Biglands, JD orcid.org/0000-0002-1161-5022, Grainger, AJ et al. (6 more authors) (2021) Quantitative MRI in myositis patients: comparison with healthy volunteers and radiological visual assessment. Clinical Radiology, 76 (1). 81 e.1-81 e.10. ISSN 0009-9260

Mankia, K, Gul, H and Emery, P orcid.org/0000-0002-7429-8482 (2021) Treating rheumatoid arthritis to an imaging target produces better outcomes, or does it? Rheumatology, 60 (1). pp. 3-4. ISSN 1462-0324

Fitton, J orcid.org/0000-0002-7795-8191, Melville, AR, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway. Rheumatology. ISSN 1462-0324

Di Matteo, A orcid.org/0000-0003-0867-7051, Mankia, K, Nam, JL et al. (5 more authors) (2020) In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis. Rheumatology. ISSN 1462-0324

Rooney, CM, Mankia, K, Mitra, S orcid.org/0000-0002-9378-1496 et al. (3 more authors) (2020) Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis. Rheumatology. ISSN 1462-0324

Psarras, A, Alase, A, Antanaviciute, A et al. (6 more authors) (2020) Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nature Communications, 11. 6149. ISSN 2041-1723

Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 166. 166-. ISSN 1478-6354

Calabrese, LH, Emery, P orcid.org/0000-0002-7429-8482, Kivitz, AJ et al. (1 more author) (2020) Evolving treatment paradigms for rheumatoid arthritis: Translating comprehensive patient evaluations into personalized therapy. Seminars in Arthritis and Rheumatism, 50 (6). 1549. ISSN 0049-0172

Biglands, JD orcid.org/0000-0002-1161-5022, Grainger, AJ, Robinson, P orcid.org/0000-0002-8431-9929 et al. (6 more authors) (2020) MRI in acute muscle tears in athletes: can quantitative T2 and DTI predict return to play better than visual assessment? European Radiology, 30 (12). pp. 6603-6613. ISSN 0938-7994

Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 115. ISSN 1478-6354

Emery, P orcid.org/0000-0002-7429-8482, van Hoogstraten, H, Thangavelu, K et al. (3 more authors) (2020) Subcutaneous Sarilumab in Patients with Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open-Label Extension of a Randomized Clinical Trial. ACR Open Rheumatology, 2 (11). pp. 672-680. ISSN 2578-5745

Plein, S orcid.org/0000-0002-0997-4384, Erhayiem, B, Fent, G et al. (9 more authors) (2020) Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis. Annals of the Rheumatic Diseases, 79 (11). pp. 1414-1422. ISSN 0003-4967

Di Matteo, A orcid.org/0000-0003-0867-7051, Mankia, K, Duquenne, L et al. (6 more authors) (2020) Third-Generation Anti–Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis. Arthritis & Rheumatology, 72 (11). pp. 1820-1828. ISSN 2326-5191

Duquenne, L, Chowdhury, R, Mankia, K et al. (1 more author) (2020) The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on “At-Risk” Individuals. Frontiers in Medicine, 7. 587827. ISSN 2296-858X

Cheng, Z, Do, TD orcid.org/0000-0002-5668-2181, Mankia, K et al. (7 more authors) (2020) Dysbiosis in the Oral Microbiomes of anti-CCP Positive Individuals at Risk of Developing Rheumatoid Arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Rooney, CM, Mankia, K and Emery, P orcid.org/0000-0002-7429-8482 (2020) The role of the microbiome in driving RA-related autoimmunity. Frontiers in Cell and Developmental Biology, 8. 538130. ISSN 2296-634X

Farrow, M, Biglands, J orcid.org/0000-0002-1161-5022, Tanner, SF et al. (4 more authors) (2020) Muscle deterioration due to rheumatoid arthritis: Assessment by quantitative MRI and strength testing. Rheumatology. keaa364. ISSN 1462-0324

Helliwell, PS, Coates, LC orcid.org/0000-0002-4756-663X, Chew, NS et al. (7 more authors) (2020) Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA Trial. Journal of Rheumatology, 47 (9). 181385. pp. 1338-1343. ISSN 0315-162X

Hassan, SU, Md Yusof, MY, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab. Frontiers in Medicine, 7. 498. ISSN 2296-858X

Smolen, JS, Kang, YM, Yoo, WH et al. (7 more authors) (2020) Radiographic Progression Based on Baseline Characteristics From TNF Inhibitor Biosimilar Studies in Patients With Rheumatoid Arthritis. Arthritis Research and Therapy, 22. 188. ISSN 1478-6354

McGonagle, D, O'Donnell, JS, Sharif, K et al. (2 more authors) (2020) Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors' reply. The Lancet Rheumatology, 2 (8). E460-E461. ISSN 2665-9913

Burska, A, El-Jawhari, J, Wu, J orcid.org/0000-0001-6093-599X et al. (6 more authors) (2020) Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis. Clinical and Experimental Rheumatology. ISSN 0392-856X

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O'Connor, P et al. (2 more authors) (2020) Muscle stiffness in rheumatoid arthritis is not altered or associated with muscle weakness: a shear wave elastography study. Modern Rheumatology, 30 (4). pp. 617-625. ISSN 1439-7595

Ahmad, HA, Baker, JF, Østergaard, M et al. (5 more authors) (2020) Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis. Arthritis Care & Research, 72 (7). pp. 959-964. ISSN 0893-7524

Yusof, MYM, Vital, EM orcid.org/0000-0003-1637-4755, Emery, P orcid.org/0000-0002-7429-8482 et al. (1 more author) (2020) Response to “Increased awareness of hypogammaglobulinemia after B‐cell targeting therapies” by Karim MY. Arthritis & Rheumatology, 72 (7). pp. 1231-1233. ISSN 2326-5191

Mankia, K, D'Agostino, M-A, Murillo-González, J et al. (2 more authors) (2020) Response to: ‘Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?’ by Deng et al. Annals of the Rheumatic Diseases, 79 (7). e84. ISSN 0003-4967

Di Matteo, A, Mankia, K, Duquenne, L et al. (5 more authors) (2020) Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis. Annals of the Rheumatic Diseases, 79 (7). pp. 901-907. ISSN 0003-4967

Lamana, A, Villares, R, Seoane, IV et al. (14 more authors) (2020) Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity. Frontiers in Immunology, 11. 1336. ISSN 1664-3224

Di Matteo, A orcid.org/0000-0003-0867-7051, Mankia, K, Wakefield, RJ orcid.org/0000-0001-5352-8683 et al. (1 more author) (2020) Which joints and what pathological findings should be evaluated on ultrasound in CCP+ at-risk individuals? The fifth MTP joint for bone erosions is a good starting point. Response to: ‘Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist’ by Becciolini et al. Annals of the Rheumatic Diseases. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482 and Duquenne, L (2020) It's never too soon to treat rheumatoid arthritis: finally, some supportive evidence. The Lancet Rheumatology, 2 (6). E311-E313. ISSN 2665-9913

Mankia, K, Di Matteo, A orcid.org/0000-0003-0867-7051 and Emery, P orcid.org/0000-0002-7429-8482 (2020) Prevention and cure: The major unmet needs in the management of rheumatoid arthritis. Journal of Autoimmunity, 110. 102399. ISSN 0896-8411

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Naredo, E et al. (4 more authors) (2020) Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the Rheumatic Diseases. ISSN 0003-4967

Garcia-Montoya, L, Villota-Eraso, C, Yusof, MYM et al. (2 more authors) (2020) Lessons for rituximab therapy in patients with rheumatoid arthritis. The Lancet Rheumatology. ISSN 2665-9913

McGonagle, D, O’Donnell, JS, Sharif, K et al. (2 more authors) (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatology. ISSN 2665-9913

Fautrel, B, Zhu, B, Taylor, PC et al. (8 more authors) (2020) Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison. RMD Open, 6. e001131. ISSN 2056-5933

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A et al. (11 more authors) (2020) B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 72 (5). pp. 769-779. ISSN 2326-5191

Pitaksalee, R orcid.org/0000-0002-6488-2108, Burska, AN orcid.org/0000-0003-3321-9087, Ajaib, S et al. (11 more authors) (2020) Differential CpG DNA methylation in peripheral naïve CD4+ T-cells in early rheumatoid arthritis patients. Clinical Epigenetics, 12. 54. ISSN 1868-7075

Emery, P orcid.org/0000-0002-7429-8482, Vlahos, B, Szczypa, P et al. (9 more authors) (2020) Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis. The Journal of Rheumatology, 47 (4). pp. 493-501. ISSN 0315-162X

Kay, J, Dörner, T, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar. Annals of the Rheumatic Diseases, 79 (4). e44. ISSN 0003-4967

Coates, LC orcid.org/0000-0002-4756-663X, Mahmood, F, Freeston, J orcid.org/0000-0003-0358-338X et al. (3 more authors) (2020) Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. Rheumatology, 59 (4). kez369. pp. 807-810. ISSN 1462-0324

Emery, P orcid.org/0000-0002-7429-8482, Horton, S, Dumitru, RB et al. (5 more authors) (2020) Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Annals of the Rheumatic Diseases, 79 (4). pp. 464-471. ISSN 0003-4967

Gul, HL, Eugenio, G, Rabin, T et al. (5 more authors) (2020) Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes. Rheumatology, 59 (3). kez330. pp. 613-621. ISSN 1462-0324

Mankia, K, D'Agostino, M-A and Emery, P orcid.org/0000-0002-7429-8482 (2020) Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al. Annals of the Rheumatic Diseases, 79 (3). e31. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482, Furst, DE, Kirchner, P et al. (3 more authors) (2020) Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data. Rheumatology and Therapy, 7. pp. 121-131. ISSN 2198-6584

Ponchel, F orcid.org/0000-0002-3969-7701, Burska, A orcid.org/0000-0003-3321-9087, Hunt, L et al. (6 more authors) (2020) T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management. Scientific Reports, 10. 3669. ISSN 2045-2322

Yusof, MYM, Iqbal, K, Darby, M et al. (6 more authors) (2020) Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis. Rheumatology. ISSN 1462-0324

Mankia, K, Briggs, C and Emery, P orcid.org/0000-0002-7429-8482 (2020) How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies–positive Patients Who Do Not Have Arthritis? Journal of Rheumatology, 47 (2). pp. 305-306. ISSN 0315-162X

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Smolen, JS, Choe, J-Y, Weinblatt, ME et al. (7 more authors) (2020) Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. RMD Open, 6 (1). e001096. ISSN 2056-5933

Mease, PJ, Smolen, JS, Behrens, F et al. (11 more authors) (2020) A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Annals of the Rheumatic Diseases, 79 (1). pp. 123-131. ISSN 0003-4967

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O’Connor,, P et al. (2 more authors) (2019) The effect of ageing on shear wave elastography muscle stiffness in adults. Aging Clinical and Experimental Research, 31 (12). pp. 1755-1763. ISSN 1594-0667

Mankia, K and Emery, P orcid.org/0000-0002-7429-8482 (2019) Palindromic rheumatism as part of the rheumatoid arthritis continuum. Nature Reviews Rheumatology, 15 (11). pp. 687-695. ISSN 1759-4790

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, DM et al. (7 more authors) (2019) Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 71 (11). pp. 1812-1823. ISSN 2326-5191

Burska, AN orcid.org/0000-0003-3321-9087, Thu, A, Parmar, R et al. (7 more authors) (2019) Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis. Rheumatology, 58 (11). pp. 2015-2024. ISSN 1462-0324

Traylor, M, Knevel, R, Cui, J et al. (17 more authors) (2019) Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases. PLoS ONE, 14 (10). ARTN: e0223246. ISSN 1932-6203

Tarn, JR, Howard-Tripp, N, Lendrem, DW et al. (48 more authors) (2019) Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology, 1 (2). e85-e94. ISSN 2665-9913

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Edward, S et al. (6 more authors) (2019) Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus. Lupus, 28 (11). pp. 1320-1328. ISSN 0961-2033

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O'Connor, P et al. (3 more authors) (2019) Reduction in stiffness of proximal leg muscles during the first 6 months of glucocorticoid therapy for giant cell arteritis: A pilot study using shear wave elastography. International Journal of Rheumatic Diseases, 22 (10). pp. 1891-1899. ISSN 1756-1841

Mortimer, I, Bissell, LA, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (12 more authors) (2019) Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis. Rheumatology, 58 (9). kez114. pp. 1684-1686. ISSN 1462-0324

Farrow, M, Grainger, AJ, Tan, AL orcid.org/0000-0002-9158-7243 et al. (6 more authors) (2019) Normal values and test–retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscle. British Journal of Radiology, 92 (1101). 20190143. ISSN 0007-1285

Ahmad, HA, Baker, JF, Østergaard, M et al. (3 more authors) (2019) Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial. Advances in Therapy, 36 (9). pp. 2384-2393. ISSN 0741-238X

Michaud, K, Pope, JE, Emery, P orcid.org/0000-0002-7429-8482 et al. (6 more authors) (2019) Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial. Rheumatology and Therapy, 6 (3). pp. 409-419. ISSN 2198-6584

Peterfy, C, DiCarlo, J, Emery, P orcid.org/0000-0002-7429-8482 et al. (7 more authors) (2019) Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology, 46 (8). pp. 887-895. ISSN 0315-162X

Alfuraih, AM orcid.org/0000-0002-4655-7248, O'Connor, P, Tan, AL orcid.org/0000-0002-9158-7243 et al. (4 more authors) (2019) Muscle shear wave elastography in idiopathic inflammatory myopathies: a case–control study with MRI correlation. Skeletal Radiology, 48 (8). pp. 1209-1219. ISSN 0364-2348

Mahmoud, K, Zayat, AS, Yusof, Y et al. (4 more authors) (2019) Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus. Rheumatology, 58 (8). key422. pp. 1353-1360. ISSN 1462-0324

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Ling, SF et al. (20 more authors) (2019) Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis. Rheumatology, 58 (8). pp. 1400-1409. ISSN 1462-0324

Al-Laith, M, Jasenecova, M, Abraham, S et al. (27 more authors) (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials, 20 (1). 429. p. 429. ISSN 1745-6215

Fent, G, Mankia, K, Erhayiem, B et al. (10 more authors) (2019) First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis. Annals of the Rheumatic Diseases, 78 (8). pp. 1138-1140. ISSN 0003-4967

Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) Patients achieving sustained deep remission, deep remission or sustained remission of rheumatoid arthritis are more likely than other responders to maintain remission or low disease activity after dose reduction or withdrawal of etanercept. Arthritis Research and Therapy, 21. 164. ISSN 1478-6354

Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. Arthritis Research & Therapy, 21 (1). 164. ISSN 1478-6354

Ridgley, LA, Anderson, AE, Maney, NJ et al. (7 more authors) (2019) IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function. Frontiers in Immunology, 10. 1535. ISSN 1664-3224

Taylor, PC, Lee, YC, Fleischmann, R et al. (12 more authors) (2019) Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial. Journal of Clinical Medicine, 8 (6). 831. ISSN 2077-0383

Mankia, K, Cheng, Z, Do, T orcid.org/0000-0002-5668-2181 et al. (10 more authors) (2019) Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti–Cyclic Citrullinated Protein Antibody–Positive At-Risk Adults Without Arthritis. JAMA Network Open, 2 (6). e195394. ISSN 2574-3805

Mankia, K, Cheng, Z, Do, T et al. (10 more authors) (2019) Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti–Cyclic Citrullinated Protein Antibody–Positive At-Risk Adults Without Arthritis. JAMA Network Open, 2 (6). e195394. ISSN 2574-3805

Smolen, JS, Pangan, AL, Emery, P orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2019) Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. The Lancet, 393 (10188). pp. 2303-2311. ISSN 0140-6736

Mankia, K, D'Agostino, MA, Rowbotham, E et al. (12 more authors) (2019) MRI Inflammation of the Hand Interosseous Tendons occurs in anti-CCP positive at-risk individuals and may precede the development of clinical synovitis. Annals of the Rheumatic Diseases, 78 (6). pp. 781-786. ISSN 0003-4967

van der Heijde, D, Schiff, M, Tanaka, Y et al. (6 more authors) (2019) Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis. RMD Open, 5 (1). e000898. ISSN 2056-5933

Emery, P orcid.org/0000-0002-7429-8482, Rondon, J, Parrino, J et al. (8 more authors) (2019) Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis. Rheumatology, 58 (5). pp. 849-858. ISSN 1462-0324

Braun, J, Baraliakos, X, Deodhar, A et al. (5 more authors) (2019) Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology (Oxford, England), 58 (5). pp. 859-868. ISSN 1462-0324

Hackett, KL, Davies, K, Tarn, J et al. (32 more authors) (2019) Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. RMD Open, 5 (1). e000885. ISSN 2056-5933

Savage, L, Goodfield, M, Horton, L et al. (6 more authors) (2019) Regression of peripheral subclinical enthesopathy in therapy-naïve patients treated with Ustekinumab for moderate-to-severe chronic plaque psoriasis: A Fifty‐Two–Week, Prospective, Open‐Label Feasibility Study. Arthritis and Rheumatology, 71 (4). pp. 626-631. ISSN 2326-5191

Fisher, BA, Emery, P orcid.org/0000-0002-7429-8482, Pitzalis, C et al. (2 more authors) (2019) Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren’s syndrome? Annals of the Rheumatic Diseases, 78 (4). e28-e28. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Bykerk, VP et al. (4 more authors) (2019) Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study. RMD Open, 5 (1). e000840. ISSN 2056-5933

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2019) Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International. ISSN 0172-8172

Zayat, AS, Mahmoud, K, Yusof, MYM et al. (8 more authors) (2019) Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus. Rheumatology, 58 (2). key277. pp. 304-312. ISSN 1462-0324

Abignano, G, Blagojevic, J, Bissell, L-A orcid.org/0000-0002-2789-4652 et al. (16 more authors) (2019) European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology, 58 (2). key271. pp. 254-259. ISSN 1462-0324

Mankia, K, D'Agostino, MA, Wakefield, RJ orcid.org/0000-0001-5352-8683 et al. (4 more authors) (2019) Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Annals of the Rheumatic Diseases, 78 (1). pp. 43-50. ISSN 0003-4967

Coates, LC orcid.org/0000-0002-4756-663X, Lubrano, E, Perrotta, FM et al. (3 more authors) (2019) What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis? Journal of Rheumatology, 46 (1). pp. 38-42. ISSN 0315-162X

Duquenne, L, Gul, H and Emery, P (2019) Safety evaluation of Adalimumab in immune-mediated inflammatory disorders: a rheumatological point of view. Expert opinion on drug safety, 8 (1). ISSN 1474-0338

Baraliakos, X, Conaghan, PG orcid.org/0000-0002-3478-5665, D'Agostino, M-A et al. (5 more authors) (2019) Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities. European Journal of Rheumatology, 6 (1). pp. 37-45. ISSN 2147-9720

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis. Arthritis & Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and changes of lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis: an integrated analysis. Arthritis and Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2018) On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International, 38 (12). pp. 2225-2231. ISSN 0172-8172

Cohen, SB, Burgos-Vargas, R, Emery, P et al. (3 more authors) (2018) An Extension Study of PF-05280586, a Potential Rituximab Biosimilar, versus Rituximab in Subjects with Active Rheumatoid Arthritis. Arthritis Care and Research, 70 (11). pp. 1598-1606. ISSN 0893-7524

Emery, P, Pederson, R, Bukowski, J et al. (1 more author) (2018) Predictors of Remission Maintenance after Etanercept Tapering or Withdrawal in Early Rheumatoid Arthritis: Results from the PRIZE Study. Open Rheumatology Journal, 12. pp. 179-188. ISSN 1874-3129

Tom, BDM, Symmons, D, Brockbank, S et al. (145 more authors) (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD OPEN, 4 (2). e000721. ISSN 2056-5933

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Emery, P, Pope, JE, Kruger, K et al. (4 more authors) (2018) Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review. Advances in Therapy, 35 (10). pp. 1535-1563. ISSN 0741-238X

Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (9 more authors) (2018) Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Annals of the Rheumatic Diseases, 77 (10). pp. 1432-1439. ISSN 0003-4967

Garcia-Montoya, L, Gul, H and Emery, P (2018) Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Research, 7.

Coates, LC orcid.org/0000-0002-4756-663X, Conaghan, PG orcid.org/0000-0002-3478-5665, D’Agostino, MA et al. (9 more authors) (2018) Remission in psoriatic arthritis—where are we now? Rheumatology, 57 (8). pp. 1321-1331. ISSN 1462-0324

Emery, P orcid.org/0000-0002-7429-8482, Van Keep, M, Beard, S et al. (6 more authors) (2018) Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. PharmacoEconomics, 36 (8). pp. 1015-1027. ISSN 1170-7690

Taylor, JC orcid.org/0000-0002-2518-5799, Bongartz, T, Massey, J et al. (37 more authors) (2018) Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients. The Pharmacogenomics Journal, 18 (4). pp. 528-538. ISSN 1470-269X

Taylor, PC, Kremer, JM, Emery, P et al. (14 more authors) (2018) Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies. Annals of the Rheumatic Diseases, 77 (7). pp. 988-995. ISSN 0003-4967

Brown, S orcid.org/0000-0002-1840-3786, Everett, CC orcid.org/0000-0002-9788-840X, Naraghi, K et al. (8 more authors) (2018) Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health Technology Assessment, 22 (34). ISSN 1366-5278

Oldroyd, AGS, Symmons, DPM, Sergeant, JC et al. (35 more authors) (2018) Long-term persistence with rituximab in patients with rheumatoid arthritis. Rheumatology, 57 (6). pp. 1089-1096. ISSN 1462-0324

Gillespie, J, Ross, RL, Corinaldesi, C et al. (7 more authors) (2018) Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2. Arthritis & Rheumatology, 70 (6). pp. 932-942. ISSN 2326-5191

van der Heijde, D, Dougados, M, Chen, Y-C et al. (10 more authors) (2018) Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs. RMD Open, 4 (1). e000662. ISSN 2056-5933

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Md Yusof, M et al. (8 more authors) (2018) A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. 5793. ISSN 2045-2322

Curtis, JR, Trivedi, M, Haraoui, B et al. (5 more authors) (2018) Defining and characterizing sustained remission in patients with rheumatoid arthritis. Clinical Rheumatology, 37 (4). pp. 885-893. ISSN 0770-3198

Jansen, DTSL, Emery, P, Smolen, JS et al. (6 more authors) (2018) Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study. RMD Open, 4 (1). e000564. ISSN 2056-5933

Girolomoni, G, Feldman, SR, Emery, P et al. (4 more authors) (2018) Comparison of injection‐site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study. British Journal of Dermatology, 178 (3). e215-e216. ISSN 0007-0963

O'Dwyer, JL orcid.org/0000-0002-7212-6089, Meads, DM orcid.org/0000-0003-1369-2483, Hulme, CT orcid.org/0000-0003-2077-0419 et al. (7 more authors) (2018) Cost‐Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial. Arthritis Care and Research, 70 (3). pp. 462-468. ISSN 2151-464X

Twigg, S, Hensor, EMA, Freeston, J orcid.org/0000-0003-0358-338X et al. (4 more authors) (2018) Effect of Fatigue, Older Age, Higher Body Mass Index, and Female Sex on Disability in Early Rheumatoid Arthritis in the Treatment‐to‐Target Era. Arthritis Care and Research, 70 (3). pp. 361-368. ISSN 2151-464X

Fisher, BA, Everett, CC orcid.org/0000-0002-9788-840X, Rout, J et al. (24 more authors) (2018) Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Annals of the Rheumatic Diseases, 77 (3). pp. 412-416. ISSN 0003-4967

Emery, P, Burmester, GR, Naredo, E et al. (3 more authors) (2018) Design of a Phase 4 Randomized, Double-Blind, Placebo-Controlled Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels, and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Patients (PREDICTRA). BMJ Open, 8 (2). e019007. ISSN 2044-6055

Twigg, S, Nikiphorou, E, Nam, JL et al. (6 more authors) (2018) Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis. Frontiers in Medicine, 5. 35. ISSN 2296-858X

Smolen, JS, Aletaha, D, Barton, A et al. (8 more authors) (2018) Rheumatoid arthritis. Nature Reviews Disease Primers, 4. 18001.

Dumusc, A, Ng, W-F, James, K et al. (27 more authors) (2018) Comparison of ESSDAI and ClinESSDAI in potential optimization of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry. Swiss Medical Weekly, 148 (56). w14588. ISSN 1424-7860

Burska, A orcid.org/0000-0003-3321-9087, Neilan, J, Chisman, R et al. (7 more authors) (2018) Serum IL-7 as diagnostic biomarker for Rheumatoid Arthritis: validation with EULAR-2010 classification criteria. Clinical and Experimental Rheumatology, 36 (1). 0115-0120. ISSN 0392-856X

Kavanaugh, A, van Vollenhoven, RF, Fleischmann, R et al. (7 more authors) (2018) Testing Treat-to-Target Outcomes With Initial Methotrexate Monotherapy Compared With Initial Tumor Necrosis Factor Inhibitor (Adalimumab) Plus Methotrexate in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 77 (2). pp. 289-292. ISSN 0003-4967

Kay, J, Schoels, MM, Dörner, T et al. (4 more authors) (2018) Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases. Annals of the Rheumatic Diseases, 77 (2). pp. 165-174. ISSN 0003-4967

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) Erratum: The RA-MAP Consortium: a working model for academia–industry collaboration. Nature Reviews Rheumatology, 14 (2). p. 119. ISSN 1759-4790

Alfuraih, AM, O'Connor, P, Hensor, E et al. (3 more authors) (2018) The effect of unit, depth, and probe load on the reliability of muscle shear wave elastography: Variables affecting reliability of SWE. Journal of Clinical Ultrasound, 46 (2). pp. 108-115. ISSN 1097-0096

Takase-Minegishi, K, Horita, N, Kobayashi, K et al. (7 more authors) (2018) Diagnostic test accuracy of ultrasonography for synovitis in rheumatoid arthritis: systematic review and meta-analysis. Rheumatology, 57 (1). pp. 49-58. ISSN 1462-0324

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) The RA-MAP Consortium: A working model for academia-industry collaboration. Nature Reviews Rheumatology, 14 (1). pp. 53-60. ISSN 1759-4790

Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967

Liakouli, V, Elies Comez, J, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (11 more authors) (2018) Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor. Annals of the Rheumatic Diseases, 77 (3). pp. 431-440. ISSN 0003-4967

Ouboussad, L, Hunt, L, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (5 more authors) (2017) Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis. Arthritis Research and Therapy, 19. 288. ISSN 1478-6354

Gul, HL, Garcia-Montoya, L, Duquenne, LM et al. (3 more authors) (2017) Predicting Successful Tapering of Biologic Therapy for Patients with Rheumatoid Arthritis in Remission – Why are we still using clinical remission criteria to inform decisions? Reviews Press, 1 (1). pp. 6-18.

Emery, P, Vencovský, J, Sylwestrzak, A et al. (10 more authors) (2017) 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis. Rheumatology, 56 (12). pp. 2093-2101. ISSN 1462-0324

Oni, C, Mitchell, S, James, K et al. (31 more authors) (2017) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry. Rheumatology, 56 (12). p. 2255. ISSN 1462-0324

Emery, P, Vencovský, J, Sylwestrzak, A et al. (7 more authors) (2017) Long-Term Efficacy and Safety in Patients With Rheumatoid Arthritis Continuing on SB4 or Switching From Reference Etanercept to SB4. Annals of the Rheumatic Diseases, 76 (12). pp. 1986-1991. ISSN 0003-4967

Alfuraih, AM, O'Connor, P, Tan, AL orcid.org/0000-0002-9158-7243 et al. (3 more authors) (2017) An investigation into the variability between different shear wave elastography systems in muscle. Medical Ultrasonography, 19 (4). pp. 392-400. ISSN 1844-4172

Emery, P, Mankia, K and Nam, JL (2017) Individuals at risk of rheumatoid arthritis – The evolving story. Best Practice & Research Clinical Rheumatology, 31 (1). pp. 1-2. ISSN 1521-6942

Savic, S orcid.org/0000-0001-7910-0554, Mistry, A, Wilson, AG et al. (4 more authors) (2017) Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases. RMD Open, 3. e000550. ISSN 2056-5933

Østergaard, M, Peterfy, CG, Bird, P et al. (11 more authors) (2017) The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: Updated Recommendations by the OMERACT MRI in Arthritis Working Group. The Journal of Rheumatology, 44 (11). pp. 1706-1712. ISSN 0315-162X

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, Y orcid.org/0000-0003-4791-3475 et al. (4 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 76 (11). pp. 1829-1836. ISSN 0003-4967

Glinatsi, D, Bird, P, Gandjbakhch, F et al. (6 more authors) (2017) Development and Validation of the OMERACT Rheumatoid Arthritis Magnetic Resonance Tenosynovitis Scoring System in a Multireader Exercise. Journal of Rheumatology, 44 (11). pp. 1688-1693. ISSN 0315-162X

Lau, CS, Gibofsky, A, Damjanov, N et al. (4 more authors) (2017) Down-titration of biologics for the treatment of rheumatoid arthritis: A systematic literature review. Rheumatology International, 37 (11). pp. 1789-1798. ISSN 0172-8172

Pentony, P, Duquenne, L, Dutton, K et al. (4 more authors) (2017) The Initiation of Autoimmunity at Epithelial Surfaces: a Focus on Rheumatoid Arthritis and Systemic Lupus Erythematosus. Discovery Medicine, 24 (133). pp. 191-200. ISSN 1539-6509

Bezzina, OM, Gallagher, P, Mitchell, S et al. (30 more authors) (2017) Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the discrepancy. Arthritis Care and Research, 69 (11). pp. 1714-1723. ISSN 2151-464X

Psarras, A, Emery, P and Vital, EM (2017) Type I Interferon-Mediated Autoimmune Diseases: pathogenesis, diagnosis, and targeted therapy. Rheumatology, 56 (10). pp. 1662-1675. ISSN 1462-0324

Coates, LC, Mahmood, F, Emery, P et al. (2 more authors) (2017) The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. Annals of the Rheumatic Diseases, 76 (10). ISSN 0003-4967

Keystone, EC, Breedveld, FC, Heijde, DVD et al. (8 more authors) (2017) Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone. RMD Open, 3 (2). e000445. ISSN 2056-5933

Mankia, K and Emery, P (2017) Imminent Rheumatoid Arthritis can be Identified in Primary Care. Annals of the Rheumatic Diseases, 76 (10). e42. ISSN 0003-4967

George, MD, Østergaard, M, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (3 more authors) (2017) Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis. Annals of the Rheumatic Diseases, 76 (10). pp. 1743-1746. ISSN 0003-4967

Weinblatt, ME, Bingham, CO, Burmester, G-R et al. (9 more authors) (2017) A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis. Arthritis and Rheumatology, 69 (10). pp. 1937-1948. ISSN 2326-5191

Aydin, SZ, Gunal, EK, Ozata, M et al. (4 more authors) (2017) Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission. Clinical and Experimental Rheumatology, 35 (5). pp. 853-856. ISSN 0392-856X

Cheng, Z, Meade, J, Mankia, K et al. (2 more authors) (2017) Periodontal disease and periodontal bacteria as triggers for rheumatoid arthritis. Best Practice and Research: Clinical Rheumatology, 31 (1). pp. 19-30. ISSN 1521-6942

Twigg, S, Hensor, EMA, Emery, P et al. (2 more authors) (2017) Patient-reported outcomes as predictors of change in disease activity and disability in early rheumatoid arthritis: results from Yorkshire Early Arthritis Register. Journal of Rheumatology, 44 (9). pp. 1331-1340. ISSN 0315-162X

Md Yusof, MY orcid.org/0000-0003-3131-9121, Kabia, A, Darby, M et al. (5 more authors) (2017) Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre. Rheumatology, 56 (8). pp. 1348-1357. ISSN 1462-0324

Orr, C, Vieira-Sousa, E, Boyle, DL et al. (26 more authors) (2017) Synovial tissue research: a state-of-the-art review. Nature Reviews Rheumatology, 13 (8). pp. 463-475. ISSN 1759-4790

De Marco, G, Helliwell, P, McGonagle, D et al. (4 more authors) (2017) The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes. BMC Musculoskeletal Disorders, 18. 303. ISSN 1471-2474

Baker, JF, Ostergaard, M, Emery, P et al. (2 more authors) (2017) Development and Validation of Rheumatoid Arthritis Magnetic Resonance Imaging Inflammation Thresholds Associated with Lack of Damage Progression. Clinical and Experimental Rheumatology, 35 (4). pp. 607-613. ISSN 1593-098X

Bowman, SJ, Everett, CC orcid.org/0000-0002-9788-840X, O'Dwyer, JL orcid.org/0000-0002-7212-6089 et al. (21 more authors) (2017) Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. Arthritis & Rheumatology, 69 (7). pp. 1440-1450. ISSN 2326-5191

Arumugakani, G, Stephenson, SJ, Newton, DJ orcid.org/0000-0002-0214-1486 et al. (5 more authors) (2017) Early emergence of CD19-negative human antibody secreting cells at the plasmablast to plasma cell transition. Journal of Immunology, 198 (12). pp. 4618-4628. ISSN 0022-1767

Aydin, SZ, Castillo-Gallego, C, Nam, J et al. (4 more authors) (2017) The new ACR/EULAR criteria for rheumatoid arthritis can identify patients with same disease activity but less damage by ultrasound. European Journal of Rheumatology, 4 (2). pp. 118-121. ISSN 2147-9720

Aydin, SZ, Pay, S, Inanc, N et al. (4 more authors) (2017) Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience. Clinical and Experimental Rheumatology, 35 (3). pp. 508-511. ISSN 0392-856X

Combe, B, Landewe, R, Daien, CI et al. (20 more authors) (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Annals of the Rheumatic Diseases, 76 (6). pp. 948-959. ISSN 0003-4967

Smolen, JS, Landewé, R, Bijlsma, J et al. (46 more authors) (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases, 76 (6). pp. 960-977. ISSN 0003-4967

Braun, J, Baraliakos, X, Deodhar, A et al. (8 more authors) (2017) Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Annals of the Rheumatic Diseases, 76 (6). pp. 1070-1077. ISSN 0003-4967

Mankia, K, Nam, J and Emery, P (2017) Identifying arthralgia suspicious for progression to rheumatoid arthritis. Annals of the Rheumatic Diseases, 76 (6). e14-e14. ISSN 0003-4967

Castillo-Gallego, C, Green, MJ, Aydin, SZ et al. (3 more authors) (2017) Long term follow up of an early oligoarthritis cohort shows that early aggressive intervention leads to drug free remission after 10 years: results from the LOTO study. International Journal of Clinical Rheumatology, 12 (2). pp. 12-15. ISSN 1758-4272

Ng, W-F, Miller, A, Bowman, SJ et al. (26 more authors) (2017) Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome. Rheumatology International, 37 (4). pp. 623-631. ISSN 0172-8172

Allen, PB, Olivera, P, Emery, P et al. (7 more authors) (2017) Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis. Alimentary Pharmacology and Therapeutics, 45 (8). pp. 1058-1072. ISSN 0269-2813

Emery, P, Blanco, R, Maldonado Cocco, J et al. (8 more authors) (2017) Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. RMD Open, 3 (1). e000410. ISSN 2056-5933

FitzGerald, JM and Emery, P (2017) Modifying the trajectory of asthma—are there lessons from the use of biologics in rheumatology? The Lancet, 389 (10074). pp. 1082-1084. ISSN 0140-6736

Baker, JF, Conaghan, PG orcid.org/0000-0002-3478-5665, Emery, P et al. (2 more authors) (2017) Relationship of Patient-Reported Outcomes with MRI Measures in Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 76 (3). pp. 486-490. ISSN 0003-4967

Horton, SC, Tan, AL orcid.org/0000-0002-9158-7243, Wakefield, RJ et al. (3 more authors) (2017) Ultrasound-detectable grey scale synovitis predicts future fulfilment of the 2010 ACR/EULAR RA classification criteria in patients with new-onset undifferentiated arthritis. RMD Open, 3 (1). e000394. ISSN 2056-5933

Abignano, G, Kapadia, A, Lettieri, G et al. (5 more authors) (2017) Use of optical coherence tomography for the diagnosis of preclinical lesions of circumscribed palmar hypokeratosis. Clinical and Experimental Dermatology, 42 (2). pp. 192-195. ISSN 0307-6938

Mankia, K and Emery, P (2017) What can palindromic rheumatism tell us? Best Practice & Research Clinical Rheumatology, 31 (1). pp. 90-98. ISSN 1521-6942

Sellam, J, Rivière, E, Courties, A et al. (11 more authors) (2017) Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research and Therapy, 19. 11. ISSN 1478-6354

D'Agostino, MA, Boers, M, Wakefield, RJ et al. (2 more authors) (2017) Is it time to revisit the role of ultrasound in rheumatoid arthritis management? Annals of the Rheumatic Diseases, 76 (1). pp. 7-8. ISSN 0003-4967

Buch, MH orcid.org/0000-0002-8962-5642, Hensor, EMA, Rakieh, C et al. (8 more authors) (2017) Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study. Rheumatology, 56 (1). pp. 58-67. ISSN 1462-0324

Dougados, M, Van der Heijde, D, Chen, YC et al. (11 more authors) (2017) Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: Results from the RA-BUILD study. Annals of the Rheumatic Diseases, 76 (1). pp. 88-95. ISSN 0003-4967

Emery, P, Bingham III, CO, Burmester, GR et al. (11 more authors) (2017) Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Annals of the Rheumatic Diseases, 76 (1). pp. 96-104. ISSN 0003-4967

Emery, P, Vencovskỳ, J, Sylwestrzak, A et al. (10 more authors) (2017) A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Diseases, 76 (1). pp. 51-57. ISSN 0003-4967

Sellam, J, Riviere, E, Courties, A et al. (11 more authors) (2016) Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy, 18. 294. ISSN 1478-6354

Abignano, G, Bissell, L-A, Emery, P et al. (2 more authors) (2016) Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease? Rheumatology, 55 (12). pp. 2273-2275. ISSN 1462-0324

Bissell, LA, Hensor, EMA, Kozera, L et al. (11 more authors) (2016) Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis - results from the IDEA study. Rheumatology, 55 (12). pp. 2181-2190. ISSN 1462-0324

Kremer, JM, Emery, P, Camp, HS et al. (7 more authors) (2016) A Phase 2b Study of ABT-494, a Selective JAK1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–TNF Therapy. Arthritis & Rheumatology, 68 (12). pp. 2867-2877. ISSN 2326-5191

Nam, J, Hensor, E, Hunt, L et al. (3 more authors) (2016) Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis. Annals of the Rheumatic Diseases, 75 (12). pp. 2060-2067. ISSN 0003-4967

D'Agostino, MA, Terslev, L, Wakefield, R et al. (7 more authors) (2016) Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission. Annals of the Rheumatic Diseases, 75 (11). pp. 1902-1908. ISSN 0003-4967

Bykerk, VP, Emery, P, Weinblatt, ME et al. (7 more authors) (2016) PMS82 – Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol. Value in Health. ISSN 1098-3015

Emery, P, Vencovsky, J, Ghil, J et al. (2 more authors) (2016) Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: Response to Scheinberg and Azevedo. Annals of the Rheumatic Diseases, 75 (10). e65. ISSN 0003-4967

Emery, P, Bingham III, CO, Burmester, GR et al. (11 more authors) (2016) Response to: ‘Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!’ by Boers. Annals of the Rheumatic Diseases, 75 (10). e69. ISSN 0003-4967

Hunt, L, Hensor, EM, Nam, J et al. (4 more authors) (2016) T cell subsets: An immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals. Annals of the Rheumatic Diseases, 75 (10). pp. 1884-1889. ISSN 0003-4967

Emery, P, Vencovskỳ, J, Ghil, J et al. (1 more author) (2016) Response to: ‘Lower anti-drug antibodies with etanercept biosimilar: Can Ctrough explain the differences’ by Shah. Annals of the Rheumatic Diseases, 75 (9). e61. ISSN 0003-4967

Bissell, LA, Abignano, G, Emery, P et al. (2 more authors) (2016) Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon. BMC Musculoskeletal Disorders, 17 (1). ISSN 1471-2474

Horton, L, Emery, P and Marshall, P orcid.org/0000-0002-2505-4377 (2016) Development and assessment of inter- and intra-rater reliability of a novel ultrasound tool for scoring tendon and sheath disease – A pilot study. Ultrasound, 24 (3). pp. 134-141. ISSN 1742-271X

Nadesalingam, K, Goodfield, M and Emery, P (2016) Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy. Oxford Medical Case Reports, 2016 (8). pp. 154-156. ISSN 2053-8855

Emery, P, Smolen, JS, Ganguli, A et al. (5 more authors) (2016) Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate. Rheumatology, 55 (8). pp. 1458-1465. ISSN 1462-0324

Nam, JL, Hunt, L, Hensor, EMA et al. (1 more author) (2016) Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms – a cohort study. Annals of the Rheumatic Diseases, 75 (8). pp. 1452-1456. ISSN 0003-4967

Peterfy, C, Burmester, GR, Bykerk, VP et al. (7 more authors) (2016) Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis. Annals of the Rheumatic Diseases, 75 (8). pp. 1501-1505. ISSN 0003-4967

Schett, G, Emery, P, Tanaka, Y et al. (5 more authors) (2016) Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: Current evidence and future directions. Annals of the Rheumatic Diseases, 75 (8). pp. 1428-1437. ISSN 0003-4967

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

Emery, P, Vencovský, J, Kang, JW et al. (1 more author) (2016) Confirmation on the immunogenicity assay used in the SB4 phase III study: Response to the comments by Meacci et al. Annals of the Rheumatic Diseases, 75 (7). e40. ISSN 0003-4967

Horton, SC, Tan, AL, Freeston, JE et al. (3 more authors) (2016) Discordance between the predictors of clinical and imaging remission in patients with early rheumatoid arthritis in clinical practice: implications for the use of ultrasound within a treatment to target strategy. Rheumatology, 55 (7). pp. 1177-1187. ISSN 1462-0324

Emery, P, Vencovský, J, Ghil, J et al. (1 more author) (2016) Response to: 'Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration’ by Marshall et al. Annals of the Rheumatic Diseases, 75 (7). e38-e38. ISSN 0003-4967

Cohen, S, Emery, P, Greenwald, M et al. (8 more authors) (2016) A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis. British Journal of Clinical Pharmacology, 82 (1). pp. 129-138. ISSN 0306-5251

Baker, JF, Conaghan, PG, Emery, P et al. (2 more authors) (2016) Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis. Annals of the Rheumatic Diseases, 75 (6). pp. 1114-1119. ISSN 0003-4967

Emery, P, Fleischmann, RM, Strusberg, I et al. (12 more authors) (2016) Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial. Arthritis Care and Research, 68 (6). pp. 744-752. ISSN 2151-464X

Emery, P (2016) Introduction: the future of rheumatoid arthritis management. Current Opinion in Rheumatology, 28 (3). p. 259. ISSN 1040-8711

Emery, P, Vencovský, J and Ghil, J (2016) Response to: ‘reporting of potential immunogenicity with biologic drugs: clarity and accuracy required’ by Moots et al. Annals of the Rheumatic Diseases, 75 (5). e25. ISSN 0003-4967

Mankia, K and Emery, P (2016) A new window of opportunity in rheumatoid arthritis: targeting at-risk individuals. Current Opinion in Rheumatology, 28 (3). pp. 260-266. ISSN 1040-8711

Mankia, K and Emery, P (2016) Preclinical Rheumatoid Arthritis: Progress towards Prevention. Arthritis and Rheumatology, 68 (4). pp. 779-788. ISSN 2326-5191

Oni, C, Mitchell, S, James, K et al. (30 more authors) (2016) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Registry (UKPSSR). Rheumatology, 55 (3). pp. 544-552. ISSN 1462-0324

Gossec, L, Smolen, JS, Ramiro, S et al. (31 more authors) (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases, 75 (3). pp. 499-510. ISSN 0003-4967

Combe, B, Furst, DE, Keystone, EC et al. (5 more authors) (2016) Certolizumab Pegol Remains an Equally Efficacious Treatment of Rheumatoid Arthritis Over a Range of Background Methotrexate Regimens. Arthritis Care and Research, 68 (3). pp. 299-307. ISSN 2151-464X

Ramiro, S, Smolen, JS, Landewé, R et al. (7 more authors) (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the Rheumatic Diseases, 75 (3). pp. 490-498. ISSN 0003-4967

Zayat, AS, Md Yusof, MY, Wakefield, RJ et al. (3 more authors) (2016) The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review. Rheumatology, 55 (3). pp. 485-494. ISSN 1462-0324

Dumitru, RB, Horton, S, Hodgson, R et al. (4 more authors) (2016) A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA). BMC Musculoskeletal Disorders, 17. 61. ISSN 1471-2474

Baraliakos, X, Borah, B, Braun, J et al. (13 more authors) (2016) Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: An observational study. Annals of the Rheumatic Diseases, 75 (2). pp. 408-412. ISSN 0003-4967

Ferreira, JF, Mohamed, AAA and Emery, P (2016) Glucocorticoids and Rheumatoid Arthritis. Rheumatic Disease Clinics of North America, 42 (1). pp. 33-46. ISSN 0889-857X

Stoffer, MA, Schoels, MM, Smolen, JS et al. (15 more authors) (2016) Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Annals of the Rheumatic Diseases, 75 (1). pp. 16-22. ISSN 0003-4967

Smolen, JS, Breedveld, FC, Burmester, GR et al. (40 more authors) (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. British Journal of Sports Medicine, 75 (1). pp. 3-15. ISSN 0306-3674

Smolen, JS, Breedveld, FC, Burmester, G et al. (40 more authors) (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the Rheumatic Diseases, 75 (1). pp. 3-15. ISSN 0003-4967

Peterfy, C, Emery, P, Tak, PP et al. (9 more authors) (2016) MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study. Annals of the Rheumatic Diseases, 75 (1). pp. 170-177. ISSN 0003-4967

Bierkarre, H, Harder, J, Cuthbert, R et al. (6 more authors) (2016) Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity. Scandinavian Journal of Rheumatology, 45 (3). pp. 188-196. ISSN 0300-9742

Baeten, D, Sieper, J, Braun, J et al. (10 more authors) (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. New England Journal of Medicine, 373 (26). pp. 2534-2548. ISSN 0028-4793

Coates, LC orcid.org/0000-0002-4756-663X, Moverley, AR, McParland, L et al. (7 more authors) (2015) Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised, controlled trial. The Lancet, 386 (10012). pp. 2489-2498. ISSN 0140-6736

Mankia, K and Emery, P (2015) Anti-Porphyromonas gingivalis antibodies in rheumatoid arthritis: comment on the article by Seror et al. Arthritis and Rheumatology, 67 (12). pp. 3329-3330. ISSN 2326-5191

Emery, P, Kavanaugh, A, Bao, Y et al. (2 more authors) (2015) Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis? Annals of the Rheumatic Diseases, 74 (12). pp. 2165-2174. ISSN 0003-4967

Ostergaard, M, Bird, P, Gandjbakhch, F et al. (14 more authors) (2015) The OMERACT MRI in Arthritis Working Group-Update on Status and Future Research Priorities. Journal of Rheumatology, 42 (12). pp. 2470-2472. ISSN 0315-162X

Mackie, SL orcid.org/0000-0003-2483-5873, Pease, CT, Fukuba, E et al. (5 more authors) (2015) Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Annals of the Rheumatic Diseases, 72 (12). pp. 2188-2192. ISSN 0003-4967

Weinblatt, ME, Fleischmann, R, van Vollenhoven, RF et al. (8 more authors) (2015) Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population. Arthritis Research and Therapy, 17. 325. ISSN 1478-6354

Hawkins, T and Emery, P (2015) Biosimilar medicines in rheumatology. Clinical Pharmacist, 7 (10). ISSN 1758-9061

Ponchel, F orcid.org/0000-0002-3969-7701, Burska, AN orcid.org/0000-0003-3321-9087, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2015) Changes in peripheral blood immune cell composition in osteoarthritis. Osteoarthritis and Cartilage, 23 (11). pp. 1870-1878. ISSN 1063-4584

Emery, P, Solem, C, Majer, I et al. (2 more authors) (2015) A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization. Rheumatology International, 35 (11). pp. 1837-1849. ISSN 0172-8172

Weinblatt, ME, Mease, P, Mysler, E et al. (7 more authors) (2015) The efficacy and safety of subcutaneous clazakizumab in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate: results from a multinational, phase IIb, randomized, double-blind, placebo/active-controlled, dose-ranging study. Arthritis and Rheumatology, 67 (10). pp. 2591-2600. ISSN 2326-5191

Gvozdenović, E, Wolterbeek, R, Allaart, CF et al. (13 more authors) (2015) Assessment of global disease activity in RA by patients and physicians: differences across countries in the METEOR Database. JCR: Journal of Clinical Rheumatology, 21 (7). pp. 349-354. ISSN 1076-1608

Mankia, K and Emery, P (2015) Is Localized Autoimmunity the Trigger for Rheumatoid Arthritis? Unravelling New Targets for Prevention. Discovery Medicine, 109. pp. 129-135. ISSN 1539-6509

Rakieh, C, Nam, JL, Hunt, L et al. (10 more authors) (2015) Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Annals of the Rheumatic Diseases, 74 (9). pp. 1659-1666. ISSN 0003-4967

Gul, HL, Ferreira, JF and Emery, P (2015) Remission in rheumatoid arthritis: is it all the same? Expert Review of Clinical Pharmacology, 8 (5). pp. 575-586. ISSN 1751-2433

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, Das, S et al. (5 more authors) (2015) Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases, 74 (9). pp. 1734-1738. ISSN 0003-4967

Genovese, MC, Silverman, GJ, Emery, P et al. (7 more authors) (2015) Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O). JCR: Journal of Clinical Rheumatology, 21 (5). pp. 231-238. ISSN 1076-1608

Rowbotham, EL, Freeston, JE, Emery, P et al. (1 more author) (2015) The prevalence of tenosynovitis of the interosseous tendons of the hand in patients with rheumatoid arthritis. European Radiology. ISSN 0938-7994

Vital, EM orcid.org/0000-0003-1637-4755, Wittmann, M orcid.org/0000-0003-2328-4926, Edward, S et al. (5 more authors) (2015) Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis and Rheumatology, 67 (6). pp. 1586-1591. ISSN 2326-5191

Buch, MH orcid.org/0000-0002-8962-5642, Silva-Fernandez, L, Carmona, L et al. (18 more authors) (2015) Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology. Annals of the Rheumatic Diseases, 74 (6). pp. 963-969. ISSN 0003-4967

Emery, P, Gottenberg, JE, Rubbert-Roth, A et al. (12 more authors) (2015) Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. Annals of the Rheumatic Diseases, 74 (6). pp. 979-984. ISSN 0003-4967

Vital, EM, Dass, S, Buch, MH orcid.org/0000-0002-8962-5642 et al. (2 more authors) (2015) An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial. Annals of the Rheumatic Diseases, 74 (6). pp. 1195-1201. ISSN 0003-4967

Smolen, JS, Emery, P, Ferraccioli, GF et al. (7 more authors) (2015) Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: The CERTAIN double-blind, randomised, placebo-controlled trial. Annals of the Rheumatic Diseases, 74 (5). pp. 843-850. ISSN 0003-4967

Zayat, AS, Ellegaard, K, Conaghan, PG et al. (5 more authors) (2015) The specificity of ultrasound-detected bone erosions for rheumatoid arthritis. Annals of the Rheumatic Diseases, 74 (5). pp. 897-903. ISSN 0003-4967

Lendrem, D, Mitchell, S, McMeekin, P et al. (28 more authors) (2015) Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome? Rheumatology, 54 (4). pp. 655-659. ISSN 1462-0324

Tan, AL orcid.org/0000-0002-9158-7243, Fukuba, E, Halliday, NA et al. (3 more authors) (2015) High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Annals of the Rheumatic Diseases, 74 (1). pp. 185-189. ISSN 0003-4967

Churchman, SM, El-Jawhari, JJ, Burska, AN et al. (5 more authors) (2014) Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis. Arthritis Research and Therapy, 16 (6). 511. ISSN 1478-6354

Coy, NCN, Brown, S, Bosworth, A et al. (15 more authors) (2014) The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug. BMC Musculoskeletal Disorders, 15. 452. ISSN 1471-2474

Ndosi, M, Hill, J, Hale, C et al. (5 more authors) (2014) The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Annals of the Rheumatic Diseases, 73 (11). 1975 - 1982 (10). ISSN 0003-4967

Vital, EM, Md Yusof, MY and Emery, P (2014) Choosing the right rituximab dose for the right patient: Comment on the article by Bredemeier et al. Arthritis Care and Research, 66 (10). 1591 - 1593. ISSN 2151-464X

Md Yusof, MY, Vital, EM and Emery, P (2014) Biologics in systemic lupus erythematosus: current options and future perspectives. British Journal of Hospital Medicine, 75 (8). 440 - 447. ISSN 1750-8460

van Laar, JM, Farge, D, Sont, JK et al. (42 more authors) (2014) Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial. Journal of the American Medical Association, 311 (24). pp. 2490-2498. ISSN 0098-7484

Backhouse, MR, Pickles, DA, Mathieson, HR et al. (4 more authors) (2014) Diurnal variation of gait in patients with rheumatoid arthritis: The DIVIGN study. Clinical Biomechanics, 29 (7). 811 - 814. ISSN 0268-0033

Fechtenbaum, M, Md Yusof, MY and Emery, P (2014) Certolizumab pegol in rheumatoid arthritis: Current update. Expert Opinion on Biological Therapy, 14 (6). 841 - 850. ISSN 1471-2598

Mathews, RJ, Robinson, JI orcid.org/0000-0001-5425-7520, Battellino, M et al. (17 more authors) (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases, 73 (6). pp. 1202-1210. ISSN 0003-4967

Nam, JL, Villeneuve, E, Hensor, EM et al. (10 more authors) (2014) A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Annals of the rheumatic diseases, 73 (6). 1027 - 1036. ISSN 0003-4967

Takase, K, Horton, SC, Ganesha, A et al. (5 more authors) (2014) What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? data from a single-centre cohort. Annals of the Rheumatic Diseases, 73 (9). 1695 - 1699. ISSN 0003-4967

Das, S, Vital, EM, Horton, S et al. (6 more authors) (2014) Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5). 909 - 912. ISSN 0003-4967

Savic, S orcid.org/0000-0001-7910-0554, Ouboussad, L, Dickie, LJ et al. (10 more authors) (2014) TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. Journal of Autoimmunity, 50. pp. 59-66. ISSN 0896-8411

Baker, JF, Conaghan, PG, Smolen, JS et al. (5 more authors) (2014) Development and validation of modified disease activity scores in rheumatoid arthritis: Superior correlation with magnetic resonance imaging-detected synovitis and radiographic progression. Arthritis and Rheumatology, 66 (4). pp. 794-802. ISSN 2326-5191

Ikeda, K, Koike, T, Wakefield, R et al. (1 more author) (2014) Is the glass half full or half empty? Comment on the article by Gärtner et al. Arthritis and Rheumatology, 66 (4). 1055 - 1056. ISSN 2326-5191

Burska, AN, Hunt, L, Boissinot, M et al. (7 more authors) (2014) Autoantibodies to posttranslational modifications in rheumatoid arthritis. Mediators of Inflammation, 2014. 492873. ISSN 0962-9351

Kang, T, Emery, P and Wakefield, RJ (2014) A brief history of ultrasound in rheumatology: where we are now. Clinical and Experimental Rheumatology, 32 (1, s80). 7 - 11. ISSN 0392-856X

Abignano, G, Cuomo, G, Buch, MH et al. (4 more authors) (2014) The enhanced liver fibrosis test: A clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis. Annals of the Rheumatic Diseases, 73 (2). pp. 420-427. ISSN 0003-4967

Brown, S, Navarro Coy, N, Pitzalis, C et al. (24 more authors) (2014) The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome. BMC Musculoskeletal Disorders, 15. 21. ISSN 1471-2474

Arumugakani, G, Vital, EM, Md Yusof, MY et al. (2 more authors) (2014) Response to: 'Which B-cell subset should we target in lupus?' By Ferraccioli and Houssiau. Annals of the Rheumatic Diseases, 73 (4). e20. ISSN 0003-4967

Nam, JL, Villeneuve, E, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (13 more authors) (2014) Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Annals of the Rheumatic Diseases, 73 (1). pp. 75-85. ISSN 0003-4967

Aydin, SZ, Tan, AL orcid.org/0000-0002-9158-7243, Hodsgon, R et al. (4 more authors) (2013) Comparison of ultrasonography and magnetic resonance imaging for the assesment of clinically defined knee enthesitis in spondyloarthritis. Clinical and Experimental Rheumatology, 31 (6). pp. 933-936. ISSN 0392-856X

Abignano, G, Aydin, SZ, Castillo-Gallego, C et al. (7 more authors) (2013) Virtual skin biopsy by optical coherence tomography: The first quantitative imaging biomarker for scleroderma. Annals of the Rheumatic Diseases, 72 (11). pp. 1845-1851. ISSN 0003-4967

Ponchel, F, Goëb, V, Parmar, R et al. (9 more authors) (2013) An immunological biomarker to predict MTX response in early RA. Annals of the Rheumatic Diseases. ISSN 0003-4967

Md Yusof, MY, Vital, EM and Emery, P (2013) B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: Current progress. Expert Review of Clinical Immunology, 9 (8). 761 - 772. ISSN 1744-666X

Aydin, SZ, Ash, ZR, Tinazzi, I et al. (10 more authors) (2013) The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Annals of the Rheumatic Diseases, 72 (6). pp. 992-995. ISSN 0003-4967

Kang, T, Horton, L, Emery, P et al. (1 more author) (2013) Value of ultrasound in rheumatologic diseases. Journal of Korean Medical Science, 28 (4). 497 - 507. ISSN 1011-8934

Md Yusof, MY and Emery, P (2013) Targeting interleukin-6 in rheumatoid arthritis. Drugs, 73 (4). 341 - 356. ISSN 0012-6667

Coates, LC, Navarro-Coy, N, Brown, SR et al. (11 more authors) (2013) The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskeletal Disorders, 14. 101. ISSN 1471-2474

Robinson, JI, Carr, IM, Cooper, DL et al. (9 more authors) (2012) Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Human Mutation, 33 (4). 741 - 749 . ISSN 1059-7794

Alcacer-Pitarch, B, Buch, MH orcid.org/0000-0002-8962-5642, Gray, J et al. (11 more authors) (2012) Pressure and pain In Systemic sclerosis/Scleroderma - an evaluation of a simple intervention (PISCES): randomised controlled trial protocol. BMC Musculoskeletal Disorders, 13. ISSN 1471-2474

Gossec, L, Smolen, JS, Gaujoux-Viala, C et al. (32 more authors) (2012) European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1). pp. 4-12. ISSN 0003-4967

Alcacer-Pitarch, B, Siddle, HJ, Buch, MH et al. (3 more authors) (2011) Foot health needs in people with systemic sclerosis: an audit of foot health care provision. Clinical Rheumatology, 30 (12). pp. 1611-1615. ISSN 0770-3198

Ndosi, M, Lewis, M, Hale, C et al. (5 more authors) (2011) A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: Study protocol of an ongoing nationwide multi-centre study. International Journal of Nursing Studies, 48 (8). 995 - 1001. ISSN 0020-7489

Ciurtin, C, Majeed, Y, Naylor, J et al. (4 more authors) (2010) TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan. BMC Musculoskeletal Disorders, 11 (1). 111. ISSN 1471-2474

Craddock, N, Hurles, ME, Cardin, N et al. (215 more authors) (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature, 464 (7289). pp. 713-720. ISSN 0028-0836

Morgan, AW orcid.org/0000-0003-1109-624X, Robinson, JI orcid.org/0000-0001-5425-7520, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (10 more authors) (2010) Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Research, 12 (2). R57. R57-R57. ISSN 1465-9913

Orozco, G, Hinks, A, Eyre, S et al. (19 more authors) (2009) Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Human Molecular Genetics, 18 (14). pp. 2693-2699. ISSN 0964-6906

Buch, MH orcid.org/0000-0002-8962-5642, Boyle, DL, Rosengren, S et al. (10 more authors) (2009) Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study. Annals of the Rheumatic Diseases, 68 (7). pp. 1220-1227. ISSN 0003-4967

Bennett, AN, McGonagle, D, O'Connor, P et al. (5 more authors) (2008) Severity of baseline magnetic resonance imaging–evident sacroiliitis and HLA–B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis & Rheumatism, 58 (11). pp. 3413-3418. ISSN 0004-3591

Buch, MH orcid.org/0000-0002-8962-5642, Vital, EM orcid.org/0000-0003-1637-4755 and Emery, P orcid.org/0000-0002-7429-8482 (2008) Abatacept in the treatment of rheumatoid arthritis. Arthritis Research and Therapy, 10 Suppl 1 (S5). S5-. ISSN 1478-6354

Hardy, RS, Rabbitt, EH, Filer, A et al. (7 more authors) (2008) Local and systemic glucocorticoid metabolism in inflammatory arthritis. Annals of the Rheumatic Diseases, 67 (9). 1204 - 1210. ISSN 0003-4967

Quinn, MA, Green, MJ, Marzo-Ortega, H et al. (5 more authors) (2003) Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis and Rheumatism, 48 (11). pp. 3039-3045. ISSN 0004-3591

Marzo-Ortega, H, McGonagle, DG, Haugeberg, G et al. (3 more authors) (2003) Bone mineral density improvement in spondyloarthropathy after treatment with etanercept. Arthritis and Rheumatism, 62 (10). pp. 1020-1021. ISSN 0004-3591

Marzo-Ortega, H, McGonagle, D, O'Connor, P et al. (1 more author) (2003) Efficacy of etanercept for treatment of Crohn’s related spondyloarthritis but not colitis. Annals of the Rheumatic Diseases, 62 (1). pp. 74-76. ISSN 0003-4967

Book Section

Bissell, LA, Adu, D and Emery, P orcid.org/0000-0002-7429-8482 (2015) The patient with rheumatoid arthritis, mixed connective tissue disease, polymyositis, Sjögren syndrome , or overlap syndromes. In: Turner, NW, Lameire, N, Goldsmith, DJ, Winearls, CJ, Himmelfarb, J, Remuzzi, G, Bennet, WG, de Broe, ME, Chapman, JR, Covic, A, Jha, V, Sheerin, N and Unwin, R, (eds.) Oxford Textbook of Clinical Nephrology. Oxford University Press . ISBN 9780199592548

Conference or Workshop Item

Md. Yusof, MY, Arnold, J, Saleem, B et al. (5 more authors) (2022) OP0250 BREAKTHROUGH INFECTIONS AND PREDICTING SEVERE COVID OUTCOMES DURING RITUXIMAB THERAPY IN AUTOIMMUNE RHEUMATIC DISEASES. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.

Arnold, J, Vital, E, Dass, S et al. (5 more authors) (2021) A Personalised Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in Anca-Associated Vasculitis. In: EULAR 2021, 02-05 Jun 2021, Virtual.

Dubash, S, Alabas, OA, Michelena, X et al. (7 more authors) (2021) Dactylitis is associated with greater disease severity, CRP, ultrasound determined synovitis, and erosive damage in DMARD-naïve early PsA. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Arnold, JE, Vital, EMJ, Dass, S et al. (5 more authors) (2021) P207 A proposal for individually tailored rituximab treatment based on clinical and B-cell biomarkers for remission maintenance in ANCA associated vasculitis. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Online.

Dubash, S, Alabas, O, Michelena, X et al. (9 more authors) (2020) SAT0401 Swollen joints are associated with ultrasound power Doppler synovitis, whereas tender joints in the absence of swelling are not: an analysis of agreement and correlation in very early DMAR naïve Psoriatic arthritis. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.

Dubash, S orcid.org/0000-0002-9303-7122, Alabas, O, Michelena, X et al. (8 more authors) (2020) SAT0413 Dactylitis is associated with disease severity and ultrasound defined erosive damage in very early, DMARD naïve Psoriatic arthritis. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.

Di Matteo, A, Mankia, K, Duquenne, L et al. (6 more authors) (2020) Third generation APCA improve prediction of clinical arthritis in at-risk individuals with positive second generation ACPA. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, Scotland, UK.

Di Matteo, A, Mankia, K, Duquenne, L et al. (6 more authors) (2019) Third Generation Anti-cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Second Generation Anti-cyclic Citrullinated Peptide Positive Subjects at Risk of Rheumatoid Arthritis. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, GA, USA.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Robinson, J, El-Sherbiny, Y et al. (4 more authors) (2019) SAT0009 THE EFFECT OF FCGR3A POLYMORPHISM ON THE INITIAL DEPTH OF B-CELL DEPLETION BY RITUXIMAB, FUNCTIONAL NK-CELL MEDIATED KILLING AND CLINICAL RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS. In: Annual European Congress of Rheumatology, EULAR 2019, 12-15 Jun 2019, Madrid, Spain.

Dutton, K, Psarras, A, El-Sherbiny, Y orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2018) OP0124 In sle patients in sustained low disease activity, novel interferon assays predict flares and glucocorticoid requirements. In: Annual European Congress of Rheumatology, EULAR 2018, 13-16 Jun 2018, Amsterdam, Netherlands.

Elies, J, Liakouli, V, Abignano, G et al. (6 more authors) (2017) SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-beta/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-beta RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA. In: 37th SEF National Meeting with guest society: the British Pharmacology Society, 18-21 Jun 2017, Barcelona, Spain.

Merashli, M, De Marco, G orcid.org/0000-0003-2406-161X, Tan, AL orcid.org/0000-0002-9158-7243 et al. (4 more authors) (2016) AB0700 Baseline Clinical Characteristics of The Leeds Sparro Early Psoriatic Arthritis Cohort: High Disease and Radiographic Involvement Are Seen Early Even in The Presence of Preserved Quality of Life. In: Annual European Congress of Rheumatology 2016, 08-11 Jun 2016, London, UK.

Merashli, M, Horton, L, Hensor, E orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) FRI0468 High Prevalence of Us Determined Subclinical Synovitis in Early Psoriatic Arthritis Correlates Better with The SJC Rather than TJC: Results from The Leeds Sparro Cohort. In: European League Against Rheumatism Annual Congress 2016, 08-11 Jun 2016, London, UK.

Yusof, MYM, Vital, E, Dass, S et al. (5 more authors) (2013) Safety of rituximab for remission maintenance in relapsing anca–associated vasculitis: repeat cycles on clinical relapse are associated with low rates of hypogammaglobulinaemia. In: Annual European Congress of Rheumatology EULAR, 12-15 Jun 2013, Spain.

Proceedings Paper

Yusof, YM, Arnold, J, Saleem, B et al. (5 more authors) (2022) Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases. In: Arthritis and Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 1559-1560.

Dubash, S, Alabas, O, Michelena, X et al. (9 more authors) (2020) Swollen Joints but Not Tender Joints Are Associated with Ultrasound Power Doppler Synovitis in Very Early DMARD Naive Psoriatic Arthritis. In: Arthritis and Rheumatology. ACR Convergence 2020, 05-09 Nov 2020, Online. Wiley-Blackwell .

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Buch, MH orcid.org/0000-0002-8962-5642 et al. (20 more authors) (2018) Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, United Kingdom. Oxford University Press .

Ouboussad, L, Hunt, L, Wong, C et al. (4 more authors) (2018) Investigating IL-6 intracellular signalling in peripheral blood cell subsets in patients at early and later stages of rheumatoid arthritis (RA). In: Annals of the Rheumatic Diseases. 38th European Workshop for Rheumatology Research, 22-24 Feb 2018, Geneva, Switzerland. BMJ Publishing Group , A31-A32.

Emery, P, van Keep, M, Beard, SM et al. (6 more authors) (2017) Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. In: Value in Health. ISPOR 20th Annual European Congress, 04-08 Nov 2017, Glasgow, Scotland. Elsevier , A534-A534.

Tan, AL orcid.org/0000-0002-9158-7243, Buch, M orcid.org/0000-0002-8962-5642, O'Reilly, D et al. (5 more authors) (2017) 21st century state of rheumatoid arthritis management in the uk. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 786.

Naraghi, K, Vojinovic, T, Nam, J et al. (4 more authors) (2017) Biologic-eligible rheumatoid arthritis patients demonstrate absence of synovitis – utility of ultrasound in the management of ra-biologic population. In: Annals of the Rheumatic Diseases. EULAR 2017, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 1016.

Freeston, JE orcid.org/0000-0003-0358-338X, Mankia, KS, D'Agostino, M-A et al. (6 more authors) (2017) Can whole body mri at baseline identify definite inflammatory arthritis patterns in undifferentiated arthritis? In: Annals of the Rheumatic Diseases. EULAR 2017, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , pp. 727-728.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2017) Laser doppler imaging: an objective outcome measure for assessment of cutaneous lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , pp. 1019-1020.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using b-cell biomarkers in systemic lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 869.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (6 more authors) (2017) Prediction of connective tissue disease in an at-risk cohort using a novel interferon stimulated gene expression score. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 91.

Roberts, C, Guillard, G, Bowes, MA et al. (12 more authors) (2017) Quantitative 3D imaging of tenosynovitis and bone marrow edema by DCE-MRI is a sensitive measure of response to therapy in rheumatoid arthritis. In: Annals of the Rheumatic Diseases. EULAR 2017, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 1010.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, D et al. (5 more authors) (2017) Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 987.

Cheng, Z, DO, T orcid.org/0000-0002-5668-2181, Mankia, K et al. (8 more authors) (2017) The subgingival microbiomes in periodontitis and health of individuals with rheumatoid arthritis and at risk of developing rheumatoid arthritis. In: Journal of Oral Microbiology. 12th European Oral Microbiology Workshop, 25-28 May 2017, Stockholm. Taylor & Francis .

Harrison, SR, Burska, AN orcid.org/0000-0003-3321-9087, Emery, P et al. (2 more authors) (2017) THE EXPRESSION OF INTERFERON-RELATED GENES IS ASSOCIATED WITH RESPONSE TO INFLIXMAB IN ANKYLOSING SPONDYLITIS: PILOT DATA. In: RHEUMATOLOGY. Rheumatology 2017, 25-27 Apr 2017, Birmingham, UK. Oxford University Press , p. 93.

Ouboussad, L, Wong, C, Hunt, L et al. (4 more authors) (2017) Effect of tocilizumab therapy on il-6 signalling pathway in early rheumatoid arthritis patients. In: Annals of the Rheumatic Diseases. EWRR, 02-04 Mar 2017, Athens. BMJ Publishing Group , A40-A40.

Hensor, EMA, McKeigue, P, Conaghan, PG et al. (13 more authors) (2016) Validity of a 2-Component Disease Activity Score for Accurate Assessment of Synovitis in Rheumatoid Arthritis. In: Arthritis and Rheumatology. ACR/ARHP Annual Meeting, 11-16 Nov 2016, Washington, DC, USA. Wiley-Blackwell .

Mahmoud, K, Zayat, A, Edwards, CJ et al. (5 more authors) (2016) An Evaluation of Clinical Outcome Measures for Musculoskeletal Lupus Using Ultrasound as A Gold Standard: Table 1. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ PUblishing Group , p. 556.

Inomata, H, Bissell, L-A orcid.org/0000-0002-2789-4652, Naraghi, K et al. (6 more authors) (2016) FRI0130 Efficacy of A Comprehensive Cardiovascular Risk Reduction Patient Education Programme in Patients with Early Inflammatory Arthritis Following A Treat To Target Therapeutic Regime. In: Annals of the Rheumatic Diseases. EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 475.

Zayat, AS, Mahmoud, K, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (4 more authors) (2016) A Prospective Study To Assess Responsiveness of Clinical and Ultrasound Outcome Measures for Musculoskeletal Sle. In: Annals of the Rheumatic Diseases. Annual European Conference of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 549.

El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Hensor, E orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2016) Surface Tetherin Is A Novel Cell-Specific Biomarker for Interferon Response in Systemic Lupus Erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 546.

Mohamed, AAA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) Type I Interferon Activity Is Associated with Mucocutaneous but Not Musculoskeletal Disease Activity in Systemic Lupus Erythematosus:. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 547.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Iqbal, K, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2016) Efficacy and Safety of Rituximab in Patients with Rheumatoid Arthritis-Related Bronchiectasis (RA-BR): Results from A Multicentre Cohort. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 996.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (4 more authors) (2016) Incomplete and Systemic Lupus Erythematosus Reveal A Different Pattern of Interferon-Stimulated Genes Up-Regulation. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , pp. 285-286.

Md Yusof, MY, Hensor, EM, Das, S et al. (3 more authors) (2016) Risk Factors for Severe Infection and Outcome of Secondary Hypogammaglobulinaemia in Patients with Autoimmune Rheumatic Diseases Treated with Rituximab: Preliminary Results from 400 Patients at A Single Centre. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 845.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Candelier, JB, Dass, S et al. (3 more authors) (2016) Validation of B Cell Depletion as A Predictor of Clinical Response and Efficacy of Retreatment of Non-Response in Rheumatoid Arthritis. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 731.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, Rawstron, A et al. (2 more authors) (2016) Validation of Highly Sensitive Flow Cytometry as A Biomarker for Rituximab in Sle: A Rationale for More Intensive Treatment To Improve Clinical Outcomes. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 296.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Cassamoali, H, Rawstron, AC et al. (4 more authors) (2016) Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre. In: Rheumatology. Rheumatology 2016, 26-28 Apr 2016, Glasgow, UK. Oxford University Press , i46-i47.

Ouboussad, L, Wong, C, Hunt, L et al. (3 more authors) (2016) A2.40 Investigating IL-6 pathway signalling kinetics in peripheral blood single cell subsets with tocilizumab therapy in patients with early rheumatoid arthritis. In: Annals of the Rheumatic Diseases. 36th European Workshop for Rheumatology Research, 25-27 Feb 2016, York, UK. BMJ Publishing Group , A31-A31.

Bowman, S, Everett, C, Bombardieri, M et al. (15 more authors) (2015) Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome. In: Arthritis and Rheumatology. 2015 ACR/ARHP Annual Meeting, 06-11 Nov 2015, San Francisco, CA. Wiley .

Navarro Coy, NC, West, RM, Pavitt, SH et al. (4 more authors) (2015) Aligning clinical trials in rheumatoid arthritis with real-life populations. In: Annals of the Rheumatic Diseases. EULAR 2015, 10-13 Jun 2015, Rome, Italy. BMJ Publishing Group , 789 - 789.

Buch, M orcid.org/0000-0002-8962-5642, O'Reilly, D, Sheeran, T et al. (2 more authors) (2015) Baseline Patient Characteristics and Treatment from an Audit of Treat to Target Recommendations for Rheumatoid Arthritis: Interim Results. In: Rheumatology. Rheumatology 2015, 28-30 Apr 2015, Manchester, UK. Oxford University Press , i97-i97.

Buch, M orcid.org/0000-0002-8962-5642, O'Reilly, D, Sheeran, T et al. (2 more authors) (2015) Compliance with Treat to Target Recommendations on Rheumatoid Arthritis and Patient Outcomes: Interim Results of a UK Multicentre Study. In: Rheumatology. Rheumatology 2015, 28-30 Apr 2015, Manchester, UK. Oxford University Press , i97-i97.

Horton, SC, Tan, AL orcid.org/0000-0002-9158-7243, Wakefield, RJ et al. (3 more authors) (2015) Predictors of Clinical and Imaging Remission in Patients with Early Rheumatoid Arthritis Managed with a Treat-to-Target Approach: Results from an Early Arthritis Clinic. In: Rheumatology. Rheumatology 2015, 28-30 Apr 2015, Manchester, UK. Oxford University Press , i76-i76.

Ponchel, F, Burska, A, Campbell, M et al. (4 more authors) (2015) Shift in blood immune cell composition in ageing and osteoarthritis patients. In: Annals of the rheumatic diseases. European Workshop of Rheumatology Research, 05-07 Mar 2015, Budapest, Hungary. BMJ Publishing Group , A10 - A11.

Burska, A orcid.org/0000-0003-3321-9087, Campbel, M, Raja, R et al. (4 more authors) (2014) Changes in Peripheral Blood Immune Cell Composition in Osteoarthritis. In: ACR Abstracts. 2014 ACR/ARHP Annual Meeting, 14-19 Nov 2014, Boston, MA, USA. American College of Rheumatology .

Parmar, R, Burska, A, Emery, P et al. (3 more authors) (2014) 1.61 T-cells expressing TLR4 and CXCR4 are associated with an RA diagnostic in early inflammatory arthritis. In: Annals of the Rheumatic Diseases. European Workshop for Rheumatology Research , 20-22 Feb 2014, Lisbon, Portugal. BMJ Publishing Group , A26 - A27.

Ndosi, ME, Lewis, M, Hale, C et al. (15 more authors) (2013) Clinical outcomes of nurse-led care for people with RA: a multicentre RCT. In: Kvien, T, (ed.) Annals of the Rheumatic Diseases. EULAR Congress, 06-09 Jun 2012, Berlin. BMJ Publishing Group Ltd & European League Against Rheumatism , 120 - 120.

Ndosi, ME, Lewis, M, Hale, C et al. (15 more authors) (2013) The cost-effectiveness of nurse-led care in people with RA. In: Moots, RJ, (ed.) Rheumatology. Rheumatology 2013, 23-25 Apr 2013, Birmingham, UK. Oxford University Press , Oxford , i10-i10.

Ndosi, ME orcid.org/0000-0002-7764-3173, Lewis, M, Hale, C et al. (15 more authors) (2012) Cost Effectiveness of Nurse-Led Care for People with Rheumatoid Arthritis: A Multicentre RCT. In: Hill, J, Hale, CA and Bird, H, (eds.) Arthritis and Rheumatism. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, 09-14 Nov 2012, Washington, DC. Arthritis and Rheumatism, Suppl (64). Wiley-Blackwell , Washington DC , p. 1718.

Freeston, JE orcid.org/0000-0003-0358-338X, Coates, LC orcid.org/0000-0002-4756-663X, Helliwell, PS et al. (4 more authors) (2010) Is There Sub-Clinical Joint Disease in Early Psoriatic Arthritis? A Clinical Comparison with Power Doppler Ultrasound. In: Rheumatology. Annual Meeting of the British Society of Rheumatology, 21-23 Apr 2010, Birmingham, UK. Oxford University Press .

This list was generated on Sat Mar 23 15:25:46 2024 GMT.